2-Amino-5-chlorothiazole-4-carboxylic acid methyl ester, 95.0%, 1g

1-ETHYL-4-OXO-7-(4-PYRIDYL)-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID, 95%, 250mg

[2-(4-METHOXYPHENYL)PHENYL]SULFONYL CHLORIDE, 95.0%, 250mg

Isopropyl palmitate, min. 90%, for synthesis, 250 ml, plastic packaging.

6-BROMO-7-FLUOROINDOLINE-2,3-DIONE, 95.0%, 250mg

2,6-Dichloro-4-methyl-1,3-benzothiazole, 95.0%, 500mg

2-Ethoxyacetic acid, 95.0%, 100g

2-tert-Butoxypyridine>98.0%(GC)5g

(R)-2-((tert-Butoxycarbonyl)amino)-3-cyclohexylpropanoic acid, 95.0%, 10g

1-(4-Hydroxy-3,5-dimethoxyphenyl)ethanone, 95.0%, 1g

3-Bromomethyl-benzenesulfonamide, 95.0%, 100mg

2-Chloro-3-hydroxy-4-methoxybenzaldehyde, 95.0%, 100g

2-(2,3-Difluoro-4-methylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 98%, 1g